HPV starts when the virus enters your body through tiny breaks or micro-abrasions in the skin, most often during sexual contact. About 85% of people will get an HPV infection at some point in their lifetime, making it the most common sexually transmitted infection. Most of these infections begin silently, with no symptoms at all, and your immune system clears the virus without you ever knowing it was there.
How the Virus Gets In
HPV can’t infect intact, healthy skin. It needs a point of entry. The virus targets the deepest layer of your skin cells, called basal keratinocytes, which are normally protected beneath several layers of tissue. When there’s a small tear, scratch, or abrasion (even one too small to see or feel), the virus gains access to the basement membrane underneath.
Once it reaches that membrane, the virus attaches to sugar-chain molecules on the surface. This initial binding triggers a shape change in the virus’s outer shell, essentially unlocking it so it can latch onto a different receptor on the skin cells themselves. As those basal cells migrate to heal the wound, they carry the virus inside with them. This is why areas of the body that experience friction during sex are the most common sites of infection: the micro-trauma from contact creates the exact entry points the virus needs.
How HPV Spreads Between People
HPV spreads most commonly during vaginal or anal sex, but penetrative sex isn’t the only route. Close skin-to-skin touching during sexual activity can also transmit the virus. This means condoms reduce the risk but don’t eliminate it entirely, since they don’t cover all the skin that comes into contact during sex.
A person can transmit HPV even when they have no visible warts or symptoms. There’s no way to know by looking at someone whether they carry the virus, which is a major reason it’s so widespread.
What Happens After Infection
Once HPV infects the basal cells, it doesn’t immediately do anything dramatic. The virus essentially hijacks the cell’s normal life cycle. As infected basal cells divide and move toward the skin’s surface, the virus uses the cell’s own machinery to make copies of itself. New viral particles are shed from the outermost skin layer, which is how the infection can spread to others.
The vast majority of HPV infections stay quiet. Your immune system detects the virus and works to suppress or eliminate it, typically within one to two years. Most people never develop any visible signs. The infections that do cause problems are the ones your immune system fails to clear.
The Timeline From Exposure to Symptoms
If you’re going to develop symptoms, they won’t appear right away. For genital warts, the incubation period ranges from three weeks to eight months, with an average of about three months. That gap between exposure and symptoms makes it nearly impossible to pinpoint exactly when or from whom you contracted the virus.
High-risk strains that can lead to cell changes and eventually cancer operate on a much longer timeline. Abnormal cell changes on the cervix or other tissues can take years or even decades to develop. This slow progression is why routine screening catches problems early, long before they become dangerous.
Low-Risk vs. High-Risk Strains
There are over 200 types of HPV, but they fall into two broad categories based on what they do once infection takes hold.
- Low-risk types (mainly types 6 and 11) cause genital warts and benign growths. More than 90% of genital wart cases trace back to these two strains. The warts themselves are not dangerous, though they can be bothersome and recurrent.
- High-risk types (mainly types 16 and 18, plus several others) don’t typically cause warts. Instead, they cause changes in infected cells that can progress from mild abnormalities to precancerous lesions to cancer over time. Low-grade abnormalities often resolve on their own. High-grade abnormalities are considered true cancer precursors and are the target of cervical screening programs.
Both categories start the same way, through the same micro-abrasion entry and basal cell infection. The difference is in what the virus does once it’s established: low-risk types trigger rapid cell growth that produces visible warts, while high-risk types interfere with the cell’s ability to regulate its own growth, slowly pushing it toward becoming cancerous.
Why Some People Are More Vulnerable
Your immune system is the main line of defense once HPV gets in. Anything that weakens immune function makes it harder for your body to clear the virus and increases the chance of a persistent infection. People living with HIV, those taking immunosuppressive medications after an organ transplant, and people being treated for autoimmune diseases all face higher risks of HPV persisting and progressing.
Smoking also plays a role. People who smoke or are regularly exposed to secondhand smoke have a higher risk of HPV-related cervical cancer. The chemicals in tobacco appear to damage cervical cells and impair the local immune response, giving the virus a better foothold.
How Vaccination Blocks the First Step
The HPV vaccine works by training your immune system to stop the virus before it ever reaches those basal cells. The vaccine contains virus-like particles made from a protein on the virus’s outer shell, the same protein the virus uses to bind to cells during that initial entry step. Your body produces antibodies against this protein, and those antibodies circulate in your blood and tissue fluids.
When vaccinated individuals are later exposed to real HPV, those antibodies neutralize the virus at the point of entry, before it can attach to the basement membrane and initiate infection. The antibody levels generated by the vaccine are significantly higher than those produced by natural infection, which is why vaccination is more reliable than prior infection at preventing reinfection. The vaccine is most effective when given before any exposure to the virus, which is why it’s recommended in adolescence.